Koyfin Home > Directory > Health Care > Aduro Biotech > Total Revenue

Aduro Biotech Total Revenue Chart (ADRO)

Aduro Biotech annual/quarterly Total Revenue from 2013 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Aduro Biotech Total Revenue for the quarter ending June 06, 2020 was $6m a 13.90% increase of 1m year over year
  • Aduro Biotech Total Revenue for the last 12 months ending June 06, 2020 was $28m a 41.40% increase of 12m year over year
  • Aduro Biotech Annual Total Revenue for 2019 was $17m a 12.58% increase of 2m from 2018
  • Aduro Biotech Annual Total Revenue for 2018 was $15m a -14.26% decrease of -2m from 2017
  • Aduro Biotech Annual Total Revenue for 2017 was $17m a -193.99% decrease of -33m from 2016
Other Income Statement Metrics:
  • Aduro Biotech EBITDA for the quarter ending December 12, 2018 was $-23m a 9.58% decrease of -2m year over year
  • Aduro Biotech Net Income for the quarter ending December 12, 2018 was $-26m a 18.34% decrease of -5m year over year
View Chart On Koyfin

Quarterly ADRO Total Revenue Data

06/2020$6m
03/2020$14m
12/2019$4m
09/2019$5m
06/2019$5m
03/2019$4m
12/2018$3m
09/2018$3m
06/2018$3m
03/2018$7m

Annual ADRO Total Revenue Data

2019$17m
2018$15m
2017$17m
2016$51m
2015$73m
2014$13m
2013$1m
2012$0m